Hospital
San Bernardino Mountains Community Hospital District
San Bernardino Mountains Community Hospital District was paid $1.58M by Medicaid between Jan 2018 and Nov 2024, across 81 billing codes. Its largest line is 0450, Emergency room services — 17% of everything it billed.
33Billing provider infoSAN BERNARDINO MOUNTAINS COMMUNITY HOSPITAL DISTRICT
LAKE ARROWHEAD, CA 92352
LAKE ARROWHEAD, CA 92352
33aNPI1245380799assigned 01/10/2007
33bProvider typeCritical Access Hospital
28Total paid$1.58M
24GClaims71,962
24DCodes billed81
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in California
Rank by total paid#22 of 30
Median peer was paid$3.14M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,814 | $559K | |
| 2019 | 27,144 | $643K | |
| 2020 | 7,518 | $148K | |
| 2021 | 5,442 | $145K | |
| 2022 | 1,367 | $39K | |
| 2023 | 692 | $19K | |
| 2024incomplete | 985 | $28K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 17% | 5,513 | 4,843 | $264K |
| Z7502 | 12% | 5,078 | 4,942 | $196K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.7% | 2,036 | 1,756 | $105K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.0% | 6,831 | 6,423 | $80K |
| 80053 | Comprehensive metabolic panel | 4.8% | 5,591 | 5,198 | $76K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.2% | 2,316 | 2,267 | $66K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.2% | 1,078 | 961 | $66K |
| Z7610 | 3.9% | 6,038 | 3,191 | $61K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3.5% | 2,479 | 2,423 | $56K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.8% | 520 | 458 | $44K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.8% | 1,964 | 377 | $44K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.4% | 609 | 556 | $38K |
69 more codes
| 80061 | Lipid panel | 2.4% | 2,411 | $38K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.3% | 111 | $36K |
| X3908 | 2.2% | 1,152 | $35K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.0% | 2,529 | $32K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.7% | 415 | $28K |
| 84439 | 1.7% | 2,224 | $26K | |
| 97139 | 1.6% | 1,013 | $25K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 140 | $24K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 267 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 724 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.0% | 615 | $16K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 92 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 727 | $14K |
| 99499 | <1% | 326 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 572 | $13K |
| 97750 | <1% | 287 | $11K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,758 | $10K |
| 87631 | <1% | 168 | $10K | |
| J3490 | Unclassified drugs | <1% | 5,180 | $9K |
| X3910 | <1% | 551 | $8K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 308 | $7K |
| 81001 | <1% | 1,533 | $7K | |
| 83690 | <1% | 496 | $5K | |
| 87070 | <1% | 388 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 543 | $4K |
| 87430 | <1% | 313 | $4K | |
| 84153 | <1% | 148 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 85 | $4K |
| 81003 | <1% | 1,343 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 40 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,175 | $3K |
| 84484 | <1% | 234 | $3K | |
| X3920 | <1% | 53 | $3K | |
| 81025 | <1% | 351 | $3K | |
| 82607 | <1% | 68 | $2K | |
| 99070 | <1% | 1,079 | $2K | |
| 74022 | <1% | 44 | $2K | |
| 87486 | <1% | 48 | $2K | |
| 87581 | <1% | 48 | $2K | |
| 82550 | <1% | 195 | $2K | |
| 83605 | <1% | 86 | $1K | |
| 73564 | <1% | 48 | $1K | |
| 85610 | <1% | 226 | $1K | |
| 87400 | <1% | 201 | $908.66 | |
| 85651 | <1% | 174 | $840.85 | |
| 82270 | <1% | 199 | $769.26 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 561 | $742.09 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 66 | $730.54 |
| 82553 | <1% | 40 | $631.22 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 14 | $596.52 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 26 | $562.75 |
| 73030 | <1% | 17 | $411.36 | |
| 85730 | <1% | 48 | $405.25 | |
| 71045 | Radiologic examination, chest; single view | <1% | 41 | $368.69 |
| 71020 | <1% | 14 | $349.58 | |
| 85379 | <1% | 27 | $336.89 | |
| 73610 | <1% | 12 | $303.43 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 100 | $256.75 |
| 80306 | <1% | 16 | $255.36 | |
| 73630 | <1% | 14 | $245.20 | |
| 0270 | <1% | 63 | $219.34 | |
| 84145 | <1% | 12 | $212.35 | |
| 87186 | <1% | 16 | $182.99 | |
| 84703 | <1% | 14 | $158.96 | |
| 87040 | <1% | 13 | $150.85 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 29 | $84.70 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 53 | $79.39 |
| 84550 | <1% | 13 | $74.18 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 12 | $16.46 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWAGGENER, YVONNE (CFO)
| Provider | Location | Paid |
|---|---|---|
| San Bernardino Mountains Community Hospital District | Lake Arrowhead, CA | $16.18M |
| San Bernardino Mountains Community Hospital District | Running Springs, CA | $1.23M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.